Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 5
2010 2
2011 3
2012 1
2013 2
2014 4
2015 3
2016 3
2017 10
2018 6
2019 4
2020 7
2021 17
2022 16
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.
Zwirner S, Abu Rmilah AA, Klotz S, Pfaffenroth B, Kloevekorn P, Moschopoulou AA, Schuette S, Haag M, Selig R, Li K, Zhou W, Nelson E, Poso A, Chen H, Amiot B, Jia Y, Minshew A, Michalak G, Cui W, Rist E, Longerich T, Jung B, Felgendreff P, Trompak O, Premsrirut PK, Gries K, Muerdter TE, Heinkele G, Wuestefeld T, Shapiro D, Weissbach M, Koenigsrainer A, Sipos B, Ab E, Zacarias MO, Theisgen S, Gruenheit N, Biskup S, Schwab M, Albrecht W, Laufer S, Nyberg S, Zender L. Zwirner S, et al. Among authors: gries k. Cell. 2024 Mar 28;187(7):1666-1684.e26. doi: 10.1016/j.cell.2024.02.023. Epub 2024 Mar 14. Cell. 2024. PMID: 38490194 Free PMC article. Clinical Trial.
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study.
Martin T, Lin Y, Agha M, Cohen AD, Htut M, Stewart AK, Hari P, Berdeja JG, Usmani SZ, Yeh TM, Olyslager Y, Goldberg JD, Schecter JM, Madduri D, Jackson CC, Deraedt W, Gries KS, Fastenau JM, Trudeau JJ, Akram M, Pacaud L, Jakubowiak A, Jagannath S. Martin T, et al. Among authors: gries ks. Lancet Haematol. 2022 Dec;9(12):e897-e905. doi: 10.1016/S2352-3026(22)00284-8. Epub 2022 Oct 7. Lancet Haematol. 2022. PMID: 36215989 Clinical Trial.
Muscle-derived factors influencing bone metabolism.
Gries KJ, Zysik VS, Jobe TK, Griffin N, Leeds BP, Lowery JW. Gries KJ, et al. Semin Cell Dev Biol. 2022 Mar;123:57-63. doi: 10.1016/j.semcdb.2021.10.009. Epub 2021 Oct 30. Semin Cell Dev Biol. 2022. PMID: 34756782 Review.
The Aging Athlete: Paradigm of Healthy Aging.
Gries KJ, Trappe SW. Gries KJ, et al. Int J Sports Med. 2022 Jul;43(8):661-678. doi: 10.1055/a-1761-8481. Epub 2022 Apr 8. Int J Sports Med. 2022. PMID: 35122228 Free article. Review.
Multitissue responses to exercise: a MoTrPAC feasibility study.
Chambers TL, Stroh AM, Chavez C, Brandt AR, Claiborne A, Fountain WA, Gries KJ, Jones AM, Kuszmaul DJ, Lee GA, Lester BE, Lynch CE, Minchev K, Montenegro CF, Naruse M, Raue U, Trappe TA, Trappe S. Chambers TL, et al. Among authors: gries kj. J Appl Physiol (1985). 2023 Aug 1;135(2):302-315. doi: 10.1152/japplphysiol.00210.2023. Epub 2023 Jun 15. J Appl Physiol (1985). 2023. PMID: 37318985 Retracted.
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
Mateos MV, Rigaudeau S, Basu S, Spicka I, Schots R, Wrobel T, Cook G, Beksac M, Gries KS, Kudva A, Tromp B, Van Rampelbergh R, Pei H, Wroblewski S, Carson R, Delioukina M, White D. Mateos MV, et al. Among authors: gries ks. J Oncol Pharm Pract. 2023 Jul;29(5):1172-1177. doi: 10.1177/10781552221103551. Epub 2022 Sep 6. J Oncol Pharm Pract. 2023. PMID: 36067063 Clinical Trial.
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
Sanchorawala V, Palladini G, Minnema MC, Jaccard A, Lee HC, Gibbs S, Mollee P, Venner C, Lu J, Schönland S, Gatt M, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Chauveau D, Gries KS, Fastenau J, Tran NP, Qin X, Vasey SY, Weiss BM, Vermeulen J, Ho KF, Merlini G, Comenzo RL, Kastritis E, Wechalekar AD. Sanchorawala V, et al. Among authors: gries ks. Am J Hematol. 2022 Jun 1;97(6):719-730. doi: 10.1002/ajh.26536. Epub 2022 Mar 30. Am J Hematol. 2022. PMID: 35293006 Free article. Clinical Trial.
Response scale selection in adult pain measures: results from a literature review.
Safikhani S, Gries KS, Trudeau JJ, Reasner D, Rüdell K, Coons SJ, Bush EN, Hanlon J, Abraham L, Vernon M. Safikhani S, et al. Among authors: gries ks. J Patient Rep Outcomes. 2018 Sep 6;2:40. doi: 10.1186/s41687-018-0053-6. eCollection 2017. J Patient Rep Outcomes. 2018. PMID: 30238085 Free PMC article. Review.
83 results